An Entity of Type: medician, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Kenneth L. Davis is chief executive officer of the Mount Sinai Health System in New York City, an American author and medical researcher who developed the Alzheimer's Disease Assessment Scale, the most widely used tool to test the efficacy of treatments for Alzheimer's disease designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic to persons with Alzheimer's disease. His research led to four of the first five FDA-approved drugs for Alzheimer's.

Property Value
dbo:abstract
  • Kenneth L. Davis is chief executive officer of the Mount Sinai Health System in New York City, an American author and medical researcher who developed the Alzheimer's Disease Assessment Scale, the most widely used tool to test the efficacy of treatments for Alzheimer's disease designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic to persons with Alzheimer's disease. His research led to four of the first five FDA-approved drugs for Alzheimer's. (en)
dbo:education
dbo:institution
dbo:knownFor
dbo:nationality
dbo:occupation
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 18621039 (xsd:integer)
dbo:wikiPageLength
  • 19301 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1114614801 (xsd:integer)
dbo:wikiPageWikiLink
dbp:education
dbp:field
dbp:knownFor
dbp:name
  • Kenneth L. Davis, MD (en)
dbp:nationality
dbp:notableWorks
  • Alzheimer's Disease Assessment Scale (en)
dbp:occupation
  • (en)
  • Chief executive officer of the Mount Sinai Health System (en)
dbp:prizes
  • George H. W. Bush Lifetime of Leadership Award (en)
dbp:website
dbp:wikiPageUsesTemplate
dbp:workInstitutions
dcterms:subject
rdf:type
rdfs:comment
  • Kenneth L. Davis is chief executive officer of the Mount Sinai Health System in New York City, an American author and medical researcher who developed the Alzheimer's Disease Assessment Scale, the most widely used tool to test the efficacy of treatments for Alzheimer's disease designed specifically to evaluate the severity of cognitive and noncognitive behavioral dysfunctions characteristic to persons with Alzheimer's disease. His research led to four of the first five FDA-approved drugs for Alzheimer's. (en)
rdfs:label
  • Kenneth L. Davis (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Kenneth L. Davis, MD (en)
is dbo:head of
is dbo:keyPerson of
is dbo:wikiPageWikiLink of
is dbp:head of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License